☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Fennec Pharmaceuticals
Fennec Pharmaceuticals and Norgine Collaborate for the Commercialization of Pedmarqsi in the EU, Australia and New Zealand
March 18, 2024
Fennec Pharmaceuticals’ Pedmarqsi (sodium thiosulfate) Receives EC’s Marketing Authorization for Cisplatin-Induced Ototoxicity
June 6, 2023
Fennec Pharmaceuticals Launches Pedmark (sodium thiosulfate injection) in the US
October 18, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.
